secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2026-02-06T23:59:59+00:00
Accession:  0001628280-26-006078
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen receives Nasdaq deficiency notice for minimum bid price non-compliance
-------------------------------------------------------------------------------

- Received Nasdaq notice on Feb 3, 2026 for non-compliance with $1.00 minimum bid price requirement.
- Stock closed below $1.00 for 30 consecutive business days; no immediate effect on listing.
- Must regain compliance by Aug 3, 2026 by having $1.00 closing bid for 10 consecutive days.
- May qualify for a second 180-day compliance period if other listing standards are met.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026006078/0001628280-26-006078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026006078/vtgn-20260203.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-006078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer